These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

630 related articles for article (PubMed ID: 32504503)

  • 21. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?
    Vilela C; Araújo B; Soares-Guedes C; Caridade-Silva R; Martins-Macedo J; Teixeira C; Gomes ED; Prudêncio C; Vieira M; Teixeira FG
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson's Disease?
    Hill AE; Wade-Martins R; Burnet PWJ
    Front Neurosci; 2021; 15():708587. PubMed ID: 34512244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut Microbiota: A Novel Therapeutic Target for Parkinson's Disease.
    Zhu M; Liu X; Ye Y; Yan X; Cheng Y; Zhao L; Chen F; Ling Z
    Front Immunol; 2022; 13():937555. PubMed ID: 35812394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unravelling the role of gut microbiota in Parkinson's disease progression: Pathogenic and therapeutic implications.
    Rani L; Mondal AC
    Neurosci Res; 2021 Jul; 168():100-112. PubMed ID: 33417973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.
    Liang Y; Cui L; Gao J; Zhu M; Zhang Y; Zhang HL
    Mol Neurobiol; 2021 Aug; 58(8):3745-3758. PubMed ID: 33825149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut microbiome in Parkinson's disease: A culprit or a bystander?
    Keshavarzian A; Engen P; Bonvegna S; Cilia R
    Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the Gut-Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders.
    Zheng Y; Bonfili L; Wei T; Eleuteri AM
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR2 and TLR4 in Parkinson's disease pathogenesis: the environment takes a toll on the gut.
    Gorecki AM; Anyaegbu CC; Anderton RS
    Transl Neurodegener; 2021 Nov; 10(1):47. PubMed ID: 34814947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multidirectional associations between the gut microbiota and Parkinson's disease, updated information from the perspectives of humoral pathway, cellular immune pathway and neuronal pathway.
    Jia X; Chen Q; Zhang Y; Asakawa T
    Front Cell Infect Microbiol; 2023; 13():1296713. PubMed ID: 38173790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease.
    Alfonsetti M; Castelli V; d'Angelo M
    Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Gut and Nonmotor Symptoms in Parkinson's Disease.
    Klingelhoefer L; Reichmann H
    Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Interplay between Gut Microbiota and Parkinson's Disease: Implications on Diagnosis and Treatment.
    Varesi A; Campagnoli LIM; Fahmideh F; Pierella E; Romeo M; Ricevuti G; Nicoletta M; Chirumbolo S; Pascale A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
    Heravi FS; Naseri K; Hu H
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the multifactorial aspects of Gut Microbiome in Parkinson's Disease.
    Pavan S; Prabhu AN; Prasad Gorthi S; Das B; Mutreja A; Shetty V; Ramamurthy T; Ballal M
    Folia Microbiol (Praha); 2022 Oct; 67(5):693-706. PubMed ID: 35583791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rethinking Parkinson Disease: Exploring Gut-Brain Interactions and the Potential Role of Exercise.
    Zapanta K; Schroeder ET; Fisher BE
    Phys Ther; 2022 May; 102(5):. PubMed ID: 35225349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Gut Dysbiosis and Microbiome Metabolites for the Development of Therapeutic Modalities for Neurological Disorders.
    Wiefels MD; Furar E; Eshraghi RS; Mittal J; Memis I; Moosa M; Mittal R; Eshraghi AA
    Curr Neuropharmacol; 2024; 22(1):123-139. PubMed ID: 36200211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does gut brain axis has an impact on Parkinson's disease (PD)?
    Elangovan A; Dahiya B; Kirola L; Iyer M; Jeeth P; Maharaj S; Kumari N; Lakhanpal V; Michel TM; Rao KRSS; Cho SG; Yadav MK; Gopalakrishnan AV; Kadhirvel S; Kumar NS; Vellingiri B
    Ageing Res Rev; 2024 Feb; 94():102171. PubMed ID: 38141735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of the gut microbiota in Parkinson's disease].
    Verugina NI; Levin OS; Lyashenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):86-91. PubMed ID: 34870920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the microbiota-gut-brain axis and intestinal microbiome dysregulation in Parkinson's disease.
    Li Q; Meng LB; Chen LJ; Shi X; Tu L; Zhou Q; Yu JL; Liao X; Zeng Y; Yuan QY
    Front Neurol; 2023; 14():1185375. PubMed ID: 37305758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.